BC
ABMD

Brinker Capital’s Abiomed Inc ABMD Stock Holding History

Brinker Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2.87M Sell
11,873
-2,526
-18% -$507K 0.09% 217
2020
Q1 		$2.09M Buy
14,399
+6,012
+72% +$998K 0.08% 227
2019
Q4 		$1.43M Sell
8,387
-2,556
-23% -$474K 0.04% 397
2019
Q3 		$1.95M Buy
10,943
+3,204
+41% +$693K 0.07% 308
2019
Q2 		$2.02M Buy
7,739
+1,819
+31% +$483K 0.07% 282
2019
Q1 		$1.69M Buy
5,920
+1,846
+45% +$614K 0.06% 326
2018
Q4 		$1.32M Sell
4,074
-983
-19% -$341K 0.06% 325
2018
Q3 		$2.27M Buy
+5,057
New +$1.99M 0.08% 248

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brinker Capital's ABMD Position: Q2 2020 in Review

Brinker Capital reduced its Abiomed Inc (ABMD) stake by 18% in Q2 2020, selling an estimated $507K and leaving 11,873 shares worth $2.87M. The position accounts for 0.09% of the portfolio, ranked #217.

Brinker Capital first reported a position in ABMD in Q3 2018 and has held it in 8 quarters since. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Brinker Capital held 11,873 shares of Abiomed Inc worth $2.87M as of Q2 2020.
  • Brinker Capital sold 2,526 Abiomed Inc shares in Q2 2020, an estimated $507K.
  • Abiomed Inc made up 0.09% of Brinker Capital's portfolio in Q2 2020, its #217 holding.
  • Brinker Capital first reported a position in Abiomed Inc in Q3 2018 and has held it in 8 quarters since.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.